Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2025-12-24 @ 3:56 PM
NCT ID:
NCT03349892
Eligibility Criteria:
Inclusion Criteria:
Documented sustained ventricular arrhythmias refractory to or not a suitable candidate for catheter based RFA ablative therapy
* Documented sustained ventricular arrhythmias refractory to or not a suitable candidate for cardiac sympathetic denervation therapy
* Documented ventricular arrhythmias refractory to or not a suitable candidate for cardiac transplantation
* Documented sustained ventricular arrhythmias refractory to or not a suitable candidate for additional medical management
* ICD in place with documented episodes recurrent VT despite best clinical management previous refusal of ICD with recurrent sustained ventricular arrhythmias
* If ischemic cardiomyopathy, myocardial infarction occurred more than one month prior to enrollment
* No history of prior radiotherapy to the chest
* Prescribed dose must be deliverable using SABR technique
* Age ≥ 18 years
* Karnofsky Performance Status (KPS) \> 70
* If a woman is of childbearing potential, a negative serum pregnancy test must be documented. Women of childbearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; or abstinence) for at least 4 weeks after study treatment.
* Ability to understand and willingness to sign a written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03349892
Study Brief:
Protocol Section:
NCT03349892